|
|
 | | | |
- close
- close
- close
- close
BearLinx Alerian MLP Select Index ETN (BSR) |
QUOTE AND NEWS
PR Newswire
May 16
Comment
MONTGOMERY, Ala. and LITTLE ROCK, Ark., May 16, 2012 /PRNewswire/ -- Summit Housing Partners, LLC of Montgomery, AL and Bailey Properties, LLC of Little Rock, AR announced they have merged to form a new company called BSR Trust. The merger creates a
Forbes
Dec 13
Comment
There were many memorable moments and great insights at the 2011 BSR Conference in San Francisco. But during the keynote address of Carlos Brito, CEO of Anheuser-Busch InBev, one simple phrase stuck in my mind: "We are not aliens". He used it to...
Forbes
Nov 9
Comment
There couldn’t have been a better way to approach the end of 2011 than at the ambitious and cheerful Net Impact conference followed by Business for Social Responsibility's (BSR) annual conference.
The Economic Times
Jul 10
Comment
Aureos Capital, private equity fund management with a focus on emerging markets, has invested $10 million in a leading Indian healthcare group BSR Super Speciality Hospitals, said a top company official.
MedPage Today
Apr 19
Comment
(MedPage Today) -- BRIGHTON, England -- Early treatment with abatacept (Orencia) plus methotrexate was associated with high rates of disease remission among methotrexate-naive rheumatoid arthritis patients in a two-year multinational study,...
MedPage Today
Apr 19
Comment
(MedPage Today) -- BRIGHTON, England -- Polymorphisms in the vascular endothelial growth factor A (VEGFA) gene are associated with the development of cardiovascular complications in patients with rheumatoid arthritis, a researcher said here.
MedPage Today
Apr 19
Comment
(MedPage Today) -- BRIGHTON, England -- Serum levels of the inflammatory marker myeloid-related protein (MRP)8/14, which typically differ among the subtypes of juvenile idiopathic arthritis, can be used to predict which children will respond to...
MedPage Today
Apr 18
Comment
(MedPage Today) -- BRIGHTON, England -- The monoclonal antibody canakinumab (Ilaris) provided rapid pain relief in acute flares of gout in patients with difficult-to-treat disease, according to results of a randomized trial reported here.
MedPage Today
Apr 15
Comment
(MedPage Today) -- BRIGHTON, England -- Infliximab (Remicade) remains an option for patients with longstanding rheumatoid arthritis who have not responded adequately to another tumor necrosis factor (TNF) inhibitor, researchers said here.
MedPage Today
Apr 14
Comment
(MedPage Today) -- BRIGHTON, England -- Treatment of early arthritis with a combination regimen of methotrexate and the tumor necrosis factor inhibitor adalimumab (Humira) both suppressed inflammation and prevented damage to bone and cartilage,...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
This article describes an exchange traded fund that tracks an index, commodity, currency, or varied basket of securites. View articles referencing this fund. |
TOP CONTRIBUTORS
BearLinx Alerian MLP Select Index ETN (BSR)
Overview
The BearLinxSM Alerian MLP Select Index ETN is linked to the Alerian MLP Select Index (ticker: AMZS) (the "Index"), which is published by the Standard & Poor's, a division of the McGraw-Hill Companies, Inc. (the "Sponsor"), in consultation with Alerian Capital Management LLC ("Alerian"). The BearLinxSM MLP Select Index ETN will track the change in the level of the Index and will pay a monthly coupon equal to the amount of dividends that would be paid from companies underlying the Index each month less a tracking fee. The Index measures the composite performance of midstream energy oriented Master Limited Partnerships ("MLPs"), and is calculated by the Sponsor using a float-adjusted, market capitalization weighted methodology. The objective of the Index is to provide investors with a comprehensive benchmark for the performance of the energy MLP universe. The MLPs underlying the Index are generally limited partnerships engaged in the exploration, marketing, mining, processing, production, storage or transportation of any mineral or natural resource. [1]
Fund Information
- Fund Manager - The Bear Stearns Companies Inc (JP Morgan)
- Inception Date - 07/20/2007
- Exchange - New York Stock Exchange Arca
- Index Ticker – BSR
- Intra-day NAV Ticker - BSR
- Expense Ratio - 0.85%
Top Holdings
| Company Name | Ticker | Price | Market Cap | Float Adjust | Weight |
| Alliance Holdings GP LP | AHGP | $30.47 | $1,824.03 | $365.64 | 0.55% |
| Alliance Resource Partners LP | ARLP | $43.83 | $1,602.02 | $905.83 | 1.36% |
| AmeriGas Partners LP | APU | $37.31 | $2,120.05 | $1,192.03 | 1.79% |
| Atlas Pipeline Partners LP | APL | $54.00 | $706.34 | $603.72 | 0.91% |
| Boardwalk Pipeline Partners LP | BWP | $34.56 | $4,017.60 | $1,012.68 | 1.52% |
| Buckeye GP Holdings LP | BGH | $28.05 | $793.82 | $294.53 | 0.44% |
| Buckeye Partners LP | BPL | $50.64 | $2,085.85 | $1,954.59 | 2.94% |
| Copano Energy LLC | CPNO | $42.09 | $1,845.79 | $1,584.44 | 2.38% |
| Crosstex Energy Inc | XTXI | $29.85 | $1,372.40 | $849.37 | 1.28% |
| Crosstex Energy LP | XTEX | $33.96 | $1,473.59 | $483.19 | 0.73% |
| Dorchester Minerals LP | DMLP | $22.50 | $635.41 | $558.63 | 0.84% |
| Eagle Rock Energy Partners LP | EROC | $23.91 | $1,341.68 | $321.69 | 0.48% |
| Enbridge Energy Partners LP | EEP | $54.28 | $4,158.45 | $2,938.40 | 4.42% |
| Energy Transfer Equity LP | ETE | $40.73 | $9,075.88 | $851.05 | 1.28% |
| Energy Transfer Partners LP | ETP | $60.50 | $8,287.14 | $4,298.81 | 6.46% |
| Enterprise Products Partners LP | EPD | $31.03 | $13,435.93 | $8,680.51 | 13.05% |
| Ferrellgas Partners LP | FGP | $24.07 | $1,515.39 | $901.18 | 1.36% |
| Hiland Holdings GP LP | HPGP | $31.76 | $686.02 | $222.70 | 0.33% |
| Inergy LP | NRGY | $35.80 | $1,778.56 | $1,115.29 | 1.68% |
| Kinder Morgan Energy Partners LP | KMP | $54.30 | $9,129.84 | $7,895.34 | 11.87% |
| Kinder Morgan Management LLC | KMR | $51.83 | $3,579.16 | $3,037.43 | 4.57% |
| Linn Energy LLC | LINE | $34.70 | $2,274.94 | $918.53 | 1.38% |
| Magellan Midstream Holdings LP | MGG | $29.28 | $1,834.29 | $644.10 | 0.97% |
| Magellan Midstream Partners LP | MMP | $45.42 | $3,022.53 | $2,953.82 | 4.44% |
| MarkWest Energy Partners LP | MWE | $35.49 | $1,295.38 | $913.31 | 1.37% |
| Natural Resource Partners LP | NRP | $38.01 | $2,034.96 | $925.95 | 1.39% |
| NuStar Energy LP | NS | $66.15 | $3,096.46 | $2,371.95 | 3.57% |
| NuStar GP Holdings LLC | NSH | $36.22 | $1,539.35 | $1,352.64 | 2.03% |
| ONEOK Partners LP | OKS | $68.19 | $5,652.36 | $3,067.14 | 4.61% |
| Penn Virginia Resource Partners LP | PVR | $30.96 | $1,427.45 | $795.32 | 1.20% |
| Plains All American Pipeline LP | PAA | $61.35 | $6,712.01 | $5,040.35 | 7.58% |
| Regency Energy Partners LP | RGNC | $25.25 | $1,203.94 | $538.95 | 0.81% |
| Star Gas Partners LP | SGU | $4.64 | $351.59 | $290.64 | 0.44% |
| Suburban Propane Partners LP | SPH | $48.33 | $1,579.15 | $1,467.99 | 2.21% |
| TC Pipelines LP | TCLP | $39.82 | $1,387.97 | $600.60 | 0.90% |
| TEPPCO Partners LP | TPP | $43.30 | $3,888.55 | $3,106.74 | 4.67% |
| Williams Partners LP | WPZ | $47.63 | $1,874.66 | $1,452.08 | 2.18% |
Holdings as of 15/06/2007
References
| |||||||
